REGULATION OF INTERLEUKIN-6 (IL-6)
REGULATION OF INTERLEUKIN-6 (IL-6)
批准号:
2569002
负责人:
E B SHACTER
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
alkanes bioassay disease /disorder model enzyme activity enzyme linked immunosorbent assay fatty acid biosynthesis immunoregulation indomethacin inflammation interleukin 6 laboratory mouse macrophage model design /development peritonitis plasma cell neoplasm prostaglandin E prostaglandin endoperoxide synthase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Interleukin-6 (IL-6) is an inflammatory cytokine with diverse functions
including regulation of the humoral and cellular immune response and
induction of thrombopoiesis. It is presently under development as a
therapeutic agent for induction of platelets following chemotherapy.
Because IL-6 is a growth factor for some hematopoietic tumors (e.g.,
multiple myeloma), clinical protocols designed to regulate the synthesis
or activity of IL-6 are also being investigated. The goal of the present
work is to elucidate the mechanisms whereby IL-6 levels are regulated in
vivo. We have developed a murine pre-clinical model for this purpose.
The experimental system involves injection of the mineral oil pristane
into the peritoneal cavities of BALB/c mice. This treatment induces a
chronic peritonitis that is accompanied by dramatically elevated levels
of intraperitoneal IL-6 as determined by bioassay and ELISA. Previous
studies showed that the elevation in IL-6 can be inhibited by
co-administration of the cyclooxygenase inhibitor indomethacin to the
mice. We have found that the pristane-induced increase in IL-6 is
associated with an elevation in endogenous prostaglandin E2 levels. The
results suggest that prostaglandins secreted by inflammatory macrophages
might be responsible for stimulating IL-6 production in the same cells
through a positive feedback loop. A similar mechanism may contribute to
the pathogenesis of human diseases in which both prostaglandins and IL-6
are chronically elevated (e.g., rheumatoid arthritis, Crohn's disease).
Our recent data indicate that the source of the PGE2 may be critical in
determining whether IL-6 synthesis is turned on or not. That is, when
peritoneal macrophages are stimulated to synthesize PGE2 through
prostaglandin synthase-1, which is expressed constitutively, little or
no IL-6 synthesis is observed. However, when the same macrophages are
stimulated to generate PGE2 through induction of prostaglandin
synthase-2, IL-6 synthesis is turned on. Current studies are aimed at
understanding the cellular mechanisms underlying this phenomenon.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOLOGICAL CONSEQUENCES OF PROTEIN OXIDATION
-
批准号:6101263
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E B SHACTER
-
依托单位:--
REGULATION OF INTERLEUKIN-6 (IL-6)
-
批准号:5200786
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E B SHACTER
-
依托单位:--
REGULATION OF INTERLEUKIN-6 (IL-6)
-
批准号:6101262
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E B SHACTER
-
依托单位:--
BIOLOGICAL CONSEQUENCES OF PROTEIN OXIDATION
-
批准号:2569003
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E B SHACTER
-
依托单位:--
REGULATION OF INTERLEUKIN-6 (IL-6)
-
批准号:6161322
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E B SHACTER
-
依托单位:--
BIOLOGICAL CONSEQUENCES OF PROTEIN OXIDATION
-
批准号:6161323
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E B SHACTER
-
依托单位:--
BIOLOGICAL CONSEQUENCES OF PROTEIN OXIDATION
-
批准号:5200787
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E B SHACTER
-
依托单位:--
BIOLOGICAL CONSEQUENCES OF PROTEIN OXIDATION
-
批准号:3748230
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E B SHACTER
-
依托单位:--
REGULATION OF INTERLEUKIN-6 (IL-6)
-
批准号:3748229
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E B SHACTER
-
依托单位:--
国内基金
海外基金
ITS-HPLC-HRMS-Bioassay多级筛选策略指导下海洋真菌中新型抗菌活性产物的发现
-
批准号:41606166
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:彭吉星
-
依托单位: